DK3300482T3 - Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer - Google Patents

Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer Download PDF

Info

Publication number
DK3300482T3
DK3300482T3 DK16797292.6T DK16797292T DK3300482T3 DK 3300482 T3 DK3300482 T3 DK 3300482T3 DK 16797292 T DK16797292 T DK 16797292T DK 3300482 T3 DK3300482 T3 DK 3300482T3
Authority
DK
Denmark
Prior art keywords
prg4
higher order
order aberrations
improve dynamic
dynamic visibility
Prior art date
Application number
DK16797292.6T
Other languages
Danish (da)
English (en)
Inventor
Benjamin D Sullivan
Edward R Truitt
Original Assignee
Lubris Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubris Llc filed Critical Lubris Llc
Application granted granted Critical
Publication of DK3300482T3 publication Critical patent/DK3300482T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
DK16797292.6T 2015-05-19 2016-05-19 Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer DK3300482T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562163753P 2015-05-19 2015-05-19
PCT/US2016/033248 WO2016187414A1 (en) 2015-05-19 2016-05-19 Use of prg4 to improve dynamic visual acuity and higher order aberrations

Publications (1)

Publication Number Publication Date
DK3300482T3 true DK3300482T3 (da) 2021-10-18

Family

ID=57320651

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16797292.6T DK3300482T3 (da) 2015-05-19 2016-05-19 Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer

Country Status (14)

Country Link
US (1) US11666529B2 (enExample)
EP (1) EP3300482B1 (enExample)
JP (2) JP7291459B2 (enExample)
CY (1) CY1124538T1 (enExample)
DK (1) DK3300482T3 (enExample)
ES (1) ES2893304T3 (enExample)
HR (1) HRP20211589T1 (enExample)
HU (1) HUE056409T2 (enExample)
LT (1) LT3300482T (enExample)
MA (1) MA42148A (enExample)
PL (1) PL3300482T3 (enExample)
PT (1) PT3300482T (enExample)
SI (1) SI3300482T1 (enExample)
WO (1) WO2016187414A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9982027B2 (en) 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
EP3250221B1 (en) 2015-01-26 2020-05-27 Lubris, Llc Use of prg4 as an anti-inflammatory agent
WO2019246522A1 (en) * 2018-06-21 2019-12-26 Lubris Llc Lubricin for use in wound healing
CN113905753A (zh) * 2019-01-15 2022-01-07 康奈尔大学 重组粘蛋白和组合物以及其使用方法
JP2023515504A (ja) * 2020-02-24 2023-04-13 ノバルティス アーゲー 組み換え産生されたポリペプチドの精製

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US7415381B2 (en) 2003-01-09 2008-08-19 Rhode Island Hospital, A Lifespan Partner Joint friction sensing
WO2005000331A2 (en) 2003-06-04 2005-01-06 Mucosal Therapeutics, Inc. Compositions for the treatment and prevention of degenerative joint disorders
WO2005102363A2 (en) 2004-04-20 2005-11-03 Mucosal Therapeutics Llc Methods of promoting cartilage healing or cartilage integration
WO2006012492A2 (en) 2004-07-23 2006-02-02 Mucosal Therapeutics Llc Compositions and methods for viscosupplementation
WO2006060473A2 (en) 2004-12-03 2006-06-08 Mucosal Therapeutics Llc Methods of treatment of injured or diseased joints with lubricin compositions
US20070111327A1 (en) 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
US8144631B2 (en) 2006-12-13 2012-03-27 Cisco Technology, Inc. Interconnecting IP video endpoints with reduced H.320 call setup time
WO2008143816A1 (en) 2007-05-15 2008-11-27 Mucosal Therapeutics Compositions and methods for reducing friction between the surface of tendons or other soft tissues
US20090068247A1 (en) 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
US8506944B2 (en) * 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
EP2285364B1 (en) 2008-05-07 2015-01-21 The Regents of The University of California Therapeutic replenishment and enrichment of ocular surface lubrication
WO2010083239A2 (en) 2009-01-13 2010-07-22 Truitt Edward R Iii Therapeutic modulation of vaginal epithelium boundary lubrication
JP2012527485A (ja) 2009-05-22 2012-11-08 ルブリス，エルエルシー． Ｐｒｇ４及びその治療調節作用の応用及び使用
WO2011019963A2 (en) 2009-08-13 2011-02-17 Singularis, Inc. Prg4 treatment for interstitial cystitis
WO2011091000A2 (en) 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
KR101413390B1 (ko) 2010-07-30 2014-06-27 노파르티스 아게 수분이 풍부한 표면을 갖는 실리콘 히드로겔 렌즈
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
US20130116186A1 (en) 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
US9982027B2 (en) 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
US10500250B2 (en) 2013-11-26 2019-12-10 Lubris Llc Compositions and methods for inhibiting intercellular interactions
US20180161393A1 (en) 2015-01-26 2018-06-14 Lubris Llc Prg4 for treating gout and its symptoms
EP3250221B1 (en) 2015-01-26 2020-05-27 Lubris, Llc Use of prg4 as an anti-inflammatory agent
US20170312335A1 (en) 2015-12-30 2017-11-02 Lubris Llc Topical use of prg4 for treatment of allergy and symptoms of inflammation

Also Published As

Publication number Publication date
JP2021167318A (ja) 2021-10-21
US11666529B2 (en) 2023-06-06
EP3300482A4 (en) 2019-02-13
EP3300482B1 (en) 2021-07-14
JP7291459B2 (ja) 2023-06-15
SI3300482T1 (sl) 2021-11-30
HUE056409T2 (hu) 2022-02-28
WO2016187414A1 (en) 2016-11-24
US20180140546A1 (en) 2018-05-24
PT3300482T (pt) 2021-10-15
CY1124538T1 (el) 2022-07-22
ES2893304T3 (es) 2022-02-08
JP2018515534A (ja) 2018-06-14
EP3300482A1 (en) 2018-04-04
MA42148A (fr) 2018-04-04
HRP20211589T1 (hr) 2022-01-07
LT3300482T (lt) 2021-10-25
PL3300482T3 (pl) 2022-01-03

Similar Documents

Publication Publication Date Title
IL269642A (en) Methods and compositions for enhancing health
HUE056337T2 (hu) Biológiai szerek és alkalmazásuk növényeknél
IL280863A (en) Autotaxin inhibitors and uses thereof
CL2016002416A1 (es) Composiciones estables de yodo no en complejo y métodos de uso
EP3344400A4 (en) Three dimensional microtissue bioprinter
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
KR20180084891A (ko) 구조 조성물 및 방법
DK3177640T3 (da) Pd-1-midler med høj affinitet og anvendelsesfremgangsmåder
EP3478308A4 (en) CANNABIS-BASED COMPOSITION AND PROCESSES
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
DK3274430T3 (da) Mikroalgesammensætninger og deres anvendelser
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
DK3261721T3 (da) Anvendelse af pridopidin til forbedring af hukommelse
IL255307B (en) Tpp1 formulations and uses thereon in cln2 disease
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
PT3319612T (pt) Oxisteróis e métodos de utilização dos mesmos
DK3381451T3 (da) Farmaceutisk sammensætning brugt til at reducere lokaliseret fedt samt brug af den farmaceutiske sammensætning
DK3182962T3 (da) Compositions and uses of amidine derivatives
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
PL3394259T3 (pl) Kompozycje i sposoby zmniejszania ekspresji tau
IL256322B (en) Improved formulations of deferasirox and methods of making the same
EP3310376A4 (en) MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
EP2983661C0 (en) OXABICYCLOHEPTANE AND OXABICYCLOHEPTENE FORMULATIONS
PT3423076T (pt) Formulações tópicas contendo ciclosporina e respetivas utilizações